Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.12−0.02 (-1.75%)
Close on Nov 13, 2026Market cap $195.18MP/E –Yield –
Palisade Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Palisade Bio's enterprise value was $77.93M on Nov 11, 2026, against $14.01M a year earlier. Over the last 5 years it ranged from -$12.60M to $222.31M, with a median of -$2.99M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $77.93M | +381.0% |
| 2025 | Dec 31, 2025 | $16.20M | – |
| 2024 | Dec 31, 2024 | -$6.06M | – |
| 2023 | Dec 29, 2023 | -$9.88M | – |
| 2022 | Dec 30, 2022 | -$5.97M | -282.4% |
| 2021 | Dec 31, 2021 | $3.27M | -96.4% |
| 2020 | Dec 31, 2020 | $90.56M | +859.3% |
| 2019 | Dec 31, 2019 | $9.44M | -58.7% |
| 2018 | Dec 31, 2018 | $22.83M | -83.9% |
| 2017 | Dec 29, 2017 | $142.24M | -24.2% |
| 2016 | Dec 30, 2016 | $187.53M | -66.4% |
| 2015 | Dec 31, 2015 | $558.54M | -60.1% |
| 2014 | Dec 31, 2014 | $1.40B | +5.4% |
| 2013 | Dec 31, 2013 | $1.33B | +205.4% |
| 2012 | Dec 31, 2012 | $435.21M | +55.7% |
| 2011 | Dec 30, 2011 | $279.53M | – |
See a number that looks wrong?